Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
BioMarin Pharmaceutical (BMRN)
NASDAQ:BMRN
RESEARCH TOOLSreports
BMRN Analyst Ratings
Strong Buy
18 Buy
5 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
BMRN Stock 12 Month Forecast
Average Price Target
$98.75
▲(43.68% Upside)
| Highest Price Target$127.00 | Average Price Target$98.75 | Lowest Price Target$70.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Truist Financial
Reiterated
02/20/25
Wells Fargo
Reiterated
02/20/25
William Blair
Reiterated
02/20/25
Barclays
Reiterated
02/20/25
Scotiabank
Reiterated
02/20/25
Stifel Nicolaus
Reiterated
02/20/25
Cantor Fitzgerald
Reiterated
02/20/25
Piper Sandler
Reiterated
02/20/25
Bernstein
Reiterated
02/20/25
Morgan Stanley
$105
Buy
52.77%
Upside
Reiterated
02/20/25
Strong Financial Performance and Positive Outlook for BioMarin Pharmaceutical
Wedbush
$94
Buy
36.77%
Upside
Reiterated
02/20/25
Wedbush Remains a Buy on BioMarin Pharmaceutical (BMRN)
TD Cowen
$120
Buy
74.60%
Upside
Reiterated
02/19/25
BioMarin Pharmaceutical's Strong Financial Performance and Growth Prospects Justify Buy RatingWe remain hopeful that commercial execution and cost discipline will drive outperformance.
Citi
$81→$82
Hold
19.31%
Upside
Reiterated
02/19/25
BioMarin Pharmaceutical: Hold Rating Amid Strong Performance and Decelerating Growth Prospects
Bank of America Securities
$101→$103
Buy
49.86%
Upside
Reiterated
02/19/25
Strong Financial Performance and Strategic Growth Drive Buy Rating for BioMarin Pharmaceutical
Best Analysts Covering BioMarin Pharmaceutical
Which Analyst Should I Follow If I Want to Buy BMRN and Sell After:
1 Month
xxx
Success Rate
14/26 ratings generated profit
Average Return
-0.39%
assigned a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 53.85% of your transactions generating a profit, with an average return of -0.39% per trade.
3 Months
xxx
Success Rate
16/36 ratings generated profit
Average Return
-0.45%
reiterated a xxx
rating 2 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 44.44% of your transactions generating a profit, with an average return of -0.45% per trade.
1 Year
Success Rate
22/46 ratings generated profit
Average Return
-2.47%
assigned a buy rating last month
Copying Cory Kasimov's trades and holding each position for 1 Year would result in 47.83% of your transactions generating a profit, with an average return of -2.47% per trade.
2 Years
xxx
Success Rate
10/22 ratings generated profit
Average Return
-5.15%
reiterated a xxx
rating 3 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 45.45% of your transactions generating a profit, with an average return of -5.15% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
BMRN Analyst Recommendation Trends
Rating
Oct 24
Nov 24
Dec 24
Jan 25
Feb 25
Strong Buy
19
17
12
7
13
Buy
44
29
11
8
12
Hold
23
19
9
3
6
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
86
65
32
18
31
Each month's total comprises the sum of three months' worth of ratings.
BMRN Financial Forecast
BMRN Stock Forecast FAQ
What is BMRN’s average 12-month price target, according to analysts?
Based on analyst ratings, BioMarin Pharmaceutical’s 12-month average price target is $98.75.
What is BMRN’s upside potential, based on the analysts’ average price target?
BioMarin Pharmaceutical has 43.68% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is BMRN a Buy, Sell or Hold?
BioMarin Pharmaceutical has a consensus rating of Strong Buy which is based on 18 buy ratings, 5 hold ratings and 0 sell ratings.
What is BioMarin Pharmaceutical’s price target?
The average price target for BioMarin Pharmaceutical is $98.75. This is based on 23 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $127.00 ,the lowest forecast is $70.00. The average price target represents 43.68% Increase from the current price of $68.73.
The highest analyst price target is $127.00 ,the lowest forecast is $70.00. The average price target represents 43.68% Increase from the current price of $68.73.
What do analysts say about BioMarin Pharmaceutical?
BioMarin Pharmaceutical’s analyst rating consensus is a Strong Buy. This is based on the ratings of 23 Wall Streets Analysts.
How can I buy shares of BMRN?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.